Table 2.
Summary of significantly different outcomes between groups
| First author (Year) | Surgery | Outcome assessments | Summary of significantly different outcomes between groups |
|---|---|---|---|
| Koh et al. (2013) [12] | TKA | C, P, PONV | Less PONV and pain in DA group, and no significant difference in complications |
| Fujii et al. (2005) [13] | TKA | C, PONV | 8 mg and 16 mg DA causes Less PONV, but 4 mg DA doesn’t work |
| Jules-Elysee et al. (2011) [14] | TKA | C, F, I, L, P, PONV | Lower IL-6 level within 12 hrs after surgery, better ROM at discharge, but a higher serum glucose level on arrival to the PACU in HC group, no difference in pain relief, PONV, LOS and complications |
| McLawhorn et al. (2014) [15] | TKA | C, L, T | Lower levels of PAP and PF1.2 while a higher serum glucose level within the first day after surgery in HC group, no significant difference in complications and LOS |
| Jules-Elysee et al. (2012) [16] | TKA | C, F, I, L, P, PONV | Less pain and lower IL-6 level within 24 hrs after surgery, better ROM at discharge, but a higher serum glucose level within the first day after surgery in HC group, no difference in PONV, LOS and complications |
| Bergeron et al. (2009) [17] | THA | C, F, P | Similar results in pain, HHS scores and complications between groups at 6 weeks and 1 year postoperatively |
| Lunn et al. (2011) [20] | TKA | C, I, L, P, PONV | MP causes better outcomes in pain, CRP levels and PONV events, but no difference in complications and LOS |
| Backes et al. (2013) [21] | TKA/ THA |
C, F, L, P, PONV | Significant pain relief, faster functional recovery, less PONV and earlier discharge in DA groups |
| Sculco et al. (2015) [22] | THA | C, I, L, P, T, | Less severe pain and lower IL-6 level while a higher serum glucose level in steroid group, no difference in the levels of PAP and PF1.2, LOS and complications |
| Lunn et al. (2013) [23] | THA | C, I, L, P, PONV | MP causes better outcomes in pain, CRP levels and PONV events, but no difference in complications and LOS |
| Kardash et al. (2007) [24] | THA | C,I,P, PONV | Less pain, PONV and lower CRP level in DA group, no difference in complications |
C: Complications and adverse events; F: Functions; I: Inflammatory factor
L: LOS, Length of stay; T: Thrombogenic markers; P: Pain
PONV: Postoperative nausea and vomiting
DA: dexamethasone; HC: Hydrocortisone; PD:prednisone; MP methylprednisolone
PAP: plasmin-alpha-2-antiplasmin complex, a kind of thrombogenic markers
PF1.2prothrombin fragment1.2, a kind of thrombogenic markers
CRP: C-reactive protein; IL-6: Interleukin-6
HHS: Harris hip score; ROM: Range of motion